Suppr超能文献

新西兰马努考郡医疗中心采用病灶内注射曲安奈德治疗良性难治性食管狭窄的疗效

Efficacy of intralesional triamcinolone injections for benign refractory oesophageal strictures at Counties Manukau Health, New Zealand.

作者信息

Ahn Yeri, Coomarasamy Christin, Ogra Ravinder

机构信息

Gastroenterology, Middlemore Hospital Counties Health, New Zealand.

出版信息

N Z Med J. 2015 Jun 12;128(1416):44-50.

Abstract

BACKGROUND AND AIMS

Refractory benign strictures of the oesophagus can present a significant clinical challenge and may require repeated attempts at dilatation. Intralesional triamcinolone injections have been used in a limited number of studies to aid in the dilatation of benign, refractory oesophageal strictures. It is hypothesised that intralesional steroid injection inhibits the scar formation, thereby reducing the need for dilatations. The purpose of this study was to assess if steroid injection reduces the need for serial endoscopic dilatations and aids in maintaining oesophageal patency.

METHOD

We report a case series of 25 patients with refractory oesophageal strictures. The mean age was 75 years and range between 41-95 years. The etiology of strictures consisted of peptic (68%), anastomotic (4%), radiation induced (16%) and eosinophilic oesophagitis (12%). Majority (75%) were distal in location. Triamcinolone (40-80 mg) was injected via 25-gauge sclerotherapy catheter in a four quadrantic manner in aliquots of 0.5 ml each into the proximal end of the stricture and also into the stricture itself after dilatation. Dilatation was carried out with over the guidewire Savary-Gilliard or through the scope (CRE) Balloon dilators depending upon the preference of the endoscopist. Dilatations were continued every 4-6 weeks until asymptomatic and/or endoscopic resolution of stricture. Periodic Dilatation Index (PDI) was calculated by the number of dilatations required over the duration of time in months.

RESULTS

The number of dilatations reduced from mean of 3.12 to 1.41 in the peptic strictures but there was no decrease in the other groups. However, the triamcinolone injection resulted in reducing the periodic dilatation index in all groups except the eosinophilic oesophagitis. The rate ratio of PDI before and after intralesional triamcinolone injection use being 0.45 with 95% confidence interval [0.30 -0.68] (p=0.0005). Furthermore triamcinolone injections showed a trend to increase the maximal achieved diameter of the strictures.

CONCLUSION

This study demonstrates the efficacy of triamcinolone intralesional steroids in reducing the requirement for repeated dilatations in refractory peptic strictures of oesophagus. Strictures related to eosinophilic oesophagitis failed to demonstrate similar efficacy.

摘要

背景与目的

难治性食管良性狭窄会带来重大的临床挑战,可能需要反复进行扩张治疗。病灶内注射曲安奈德已在少数研究中用于辅助扩张良性难治性食管狭窄。据推测,病灶内注射类固醇可抑制瘢痕形成,从而减少扩张的需求。本研究的目的是评估类固醇注射是否能减少系列内镜扩张的需求并有助于维持食管通畅。

方法

我们报告了一组25例难治性食管狭窄患者的病例系列。平均年龄为75岁,年龄范围在41至95岁之间。狭窄的病因包括消化性(68%)、吻合口(4%)、放射性诱导(16%)和嗜酸性食管炎(12%)。大多数(75%)位于远端。通过25号硬化治疗导管,以四象限方式,每次0.5毫升分份将曲安奈德(40 - 80毫克)注射到狭窄近端以及扩张后狭窄部位本身。根据内镜医师的偏好,使用导丝引导的Savary - Gilliard扩张器或通过内镜(CRE)球囊扩张器进行扩张。每4 - 6周持续进行扩张,直至无症状和/或内镜下狭窄缓解。定期扩张指数(PDI)通过在数月时间内所需扩张次数计算得出。

结果

消化性狭窄的扩张次数从平均3.12次降至1.41次,但其他组未见减少。然而,曲安奈德注射使除嗜酸性食管炎外的所有组的定期扩张指数降低。病灶内注射曲安奈德前后PDI的率比为0.45,95%置信区间为[0.30 - 0.68](p = 0.0005)。此外,曲安奈德注射显示出使狭窄最大扩张直径增加的趋势。

结论

本研究证明了病灶内注射曲安奈德类固醇在减少难治性食管消化性狭窄反复扩张需求方面的疗效。与嗜酸性食管炎相关的狭窄未显示出类似疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验